SHS is an independent private equity company focus on investments in the MedTech and Life Sciences sectors.
SHS, founded in 1993, is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics and Digital Health sectors.SHS is one of the leading healthcare growth investors in Germany and has launched five generations of funds since its foundation and invested in over 50 companies. Investments are currently being made by the fourth and fifth generations of funds. The latest fund, SHS V, is still open for subscription until end of June 2019.They do invest in young, high-growth companies as well as realize small buyouts and growth financings of established companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 6, 2019
GNA Biosolutions
|
Series C | $13.50M | Biotechnology | — |
Mar 7, 2015
GNA Biosolutions
|
Series B | €6M | Biotechnology | — |